Equities
Health CarePharmaceuticals & Biotechnology
  • Price (CAD)17.49
  • Today's Change0.16 / 0.92%
  • Shares traded561.12k
  • 1 Year change-50.51%
  • Beta-0.7749
Data delayed at least 15 minutes, as of Sep 21 2017 20:04 BST.
More ▼

Key statistics

As of last trade, Valeant Pharmaceuticals International Inc (VRX:TOR) traded at 17.49, 56.16% above the 52 week low of 11.20 set on Apr 24, 2017.
52-week range
Today
11.20Apr 24 201736.65Sep 23 2016
Markit short selling activity
Low
Med
High
Open17.33
High17.75
Low17.12
Bid17.49
Offer17.50
Previous close17.33
Average volume1.22m
Shares outstanding347.33m
Free float343.64m
P/E (TTM)--
Market cap6.02bn CAD
EPS (TTM)-4.04
CAD
Data delayed at least 15 minutes, as of Sep 21 2017 20:04 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.